retatrutide trial news today Amid the growing demand for GLP-1 medications for weight loss, a new experimental drug, retatrutide, stands out, according to new clinical results released on Thursday., ABC News' Youri New Tirzepatide & Retatrutide dual

Experimental: Not currently USP sourced or FDA approved (research use only high risk) Final Thoughts When Comparing different GLP-1 drugs including Semaglutide, retatrutide, and tirzepatide, its important to remember they are all medications used to manage obesity and type 2 diabetes, but they differ in their mechanisms and benefits

Potential Benefits Wound healing (preclinical): Animal studies report faster wound healing and tissue repair via enhanced angiogenesis and cell migration [5] [6]

If included in your protocol, sun exposure should generally be limited to 1020 minutes after dosing and adjusted based on your skin type, UV index, and provider guidance

Your regular periods will return about three months after stopping these medications

Available online at: (Accessed April 19, 2025)